Your browser doesn't support javascript.
loading
Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.
Sparidans, Rolf W; Martens, Irene; Valkenburg-van Iersel, Liselot B J; den Hartigh, Jan; Schellens, Jan H M; Beijnen, Jos H.
Affiliation
  • Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, CG Utrecht, The Netherlands. R.W.Sparidans@uu.nl
J Chromatogr B Analyt Technol Biomed Life Sci ; 879(21): 1851-6, 2011 Jul 01.
Article in En | MEDLINE | ID: mdl-21622034
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Antineoplastic Combined Chemotherapy Protocols / Chromatography, Liquid / Tandem Mass Spectrometry / Melphalan Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: J Chromatogr B Analyt Technol Biomed Life Sci Journal subject: ENGENHARIA BIOMEDICA Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Antineoplastic Combined Chemotherapy Protocols / Chromatography, Liquid / Tandem Mass Spectrometry / Melphalan Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: J Chromatogr B Analyt Technol Biomed Life Sci Journal subject: ENGENHARIA BIOMEDICA Year: 2011 Document type: Article Affiliation country: Country of publication: